Share
1,416 Posts.
lightbulb Created with Sketch. 254
clock Created with Sketch.
28/01/22
19:13
Share
Originally posted by Tian8824:
↑
Well put. The investors “gave up”. Their selling is based mostly on emotion when the pain and disappointment they cannot take another day Problem is, they don’t gain much from selling. They are not BRN brain chip holders selling at the top 5000m market cap based on no revenue. They are selling at a huge loss whatever scrap they have left. It will only give them peace of mind. maybe some feeling of vindication if the company collapses. But financially it doesn’t make sense UNLESS the selling is for tax reasons. Or they feel there is opportunity to sell now and buy back at cheap. But that’s doing a short term trade at the worst time possible. Even if they got it right, it does not validate them. Why weren’t they selling at 80 bucks??? I am not trying to pump the stock up. But my philosophy is to look at the merits of a company when it is completely almost down and out. I’m not going to look at the Merits of Bitcoin when it’s 300k. I do that when Bitcoin WAS 1c Except OSP is not at that stage. Progress is not as fast or smooth as one would hope for mostly not because of bad management, but because of Coronavirus. It needs maybe abit more time and maybe a final cap raise to get through this third variant of Coronavirus. The numbers of deaths and hospitalisations are easing as we speak. Then it’s contracts with Canada, Middle East, Asia, Europe, USA. Every continent of the world.
Expand
That's not true. The act is that they simply do not have enough evidence backing teh product to make it a standard in hospitals. The case is simply not convincing enough. If it was convincing the NHS would have bought it. I note that it is not standard in Australia either where it was created. There is not a compelling enough case to warrant the additional cost to the system hence it is not funded.